Web Content Viewer
Actions
3701:1-40 - Licensing of Radioactive Material

***To view this set of Rules, click the "Download" button located on this page
        

Chapters/Rules Description
MEMO Memo to Interested Parties
3701:1-40-01 (NC) Definitions
3701:1-40-02 (NC) Scope
3701:1-40-03 (NC) Activities requiring license
3701:1-40-04 Communications (To be recsinded)
3701:1-40-04 Communications (New)
3701:1-40-05 (NC) Completeness and accuracy of information
3701:1-40-06 Department of energy contractors (To be amended)
3701:1-40-07 (NC) Carriers
3701:1-40-08 (NC) Exempt concentrations
3701:1-40-08 APP (NC) Appendix - Exempt Concentrations
3701:1-40-09 (NC) Certain items containing radioactive material
3701:1-40-10 Certain industrial devices (To be amended)
3701:1-40-11 Exempt quantities (To be amended)
3701:1-40-11 APP (NC) Exempt Quantities
3701:1-40-12 Self-luminous products containing tritium, krypton-85, or promethium-147 (To be amended)
3701:1-40-13 Gas and aerosol detectors containing radioactive material (To be amended)
3701:1-40-14 Application for specific licenses (To be amended)
3701:1-40-14 APP A (NC) Quantities of Radioactive Materials Requiring Consideration of the Need for an Emergency Plan for Responding to a Release
3701:1-40-15 (NC) General requirements for issuance of specific licenses
3701:1-40-16 (NC) Terms and conditions of licenses
3701:1-40-17 Financial assurance and record keeping for decommissioning
3701:1-37-17 APP A (NC) Appendix A
3701:1-37-17 APP B Appendix B - Criteria relating to use of financial tests and parent company guarantees for providing reasonable assurance of funds for decommissioning (To be amended)
3701:1-40-17 APP C Appendix C - Criteria relating to use of financial tests and self guarantees for providing reasonable assurance of funds for decommissioning by companies that issue bonds (To be amended)
3701:1-40-17 APP D Appendix D - Criteria relating to use of financial tests and self-guarantee for providing reasonable assurance of funds for decommissioning by commercial companies that have no outstanding rated bonds (To be amended)
3701:1-40-17 APP E Appendix E - Criteria relating to use of financial tests and self-guarantees for providing reasonable assurance of funds for decommissioning by nonprofit colleges, universities, hospitals or nonprofit research and development entities (To be amended)
3701:1-40-17 APP F (NC) Appendix F - Wording for an escrow agreement
3701:1-40-18 Expiration or termination of license; decommissioning of sites and separate buildings or outdoor areas (To be amended)
3701:1-40-19 (NC) Transfer of radioactive material
3701:1-40-20 Reporting requirements (To be amended)
3701:1-40-21 Records (To be amended)
3701:1-40-22 (NC) Specific licenses of brad scope
3701:1-40-22 APP A Appendix A
3701:1-40-23 (NC) Requirements for the issuance of a type A specific license of broad scope
3701:1-40-24 (NC) Requirements for the issuance of a type B specific license of broad scope
3701:1-40-25 (NC) Requirements for the issuance of a type C specific license of broad scope
3701:1-40-26 (NC) Conditions of specific licenses of broad scope
3701:1-40-27 (NC) Exemptions and continued regulatory authority in agreement states and in offshore waters under section 274 of the Atomic Energy Act (To be amended)
3701:1-40-28 (NC) Recognition of agreement state licenses - reciprocity
3701:1-40-29 Funds for reclamation of radioactive material (To be amended)
3701:1-40-30 Preliminary procedures for environmental review (To be amended)
3701:1-40-31 (NC) Determination to prepare bureau assessment report; eligibility for categorical exclusion
3701:1-40-32 (NC) Finding of no significant impact
3701:1-40-33 Environmental report (To be amended)
3701:1-40-33 APP Appendix (To be rescinded)
3701:1-40-34 (NC) Bureau assessment report
3701:1-40-35 Final publishing of bureau assessment report (To be amended)
3701:1-40-36 (NC) Requirement to provide a decision
3701:1-40-37 Bureau assessment report; public notice (To be amended)
3701:1-40-38 Public participation process (To be amended)
3701:1-40-39 (NC) Radioactive drug:  capsules containing carbon-14 urea for "in vivo" diagnostic used for humans
3701:1-40 BIA Business Impact Analysis

*(NC) - No Change to the rule